Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Animal models of SARS-CoV-2 transmission
Rory D. de Vries, Barry Rockx, Bart L. Haagmans, et al.
Current Opinion in Virology (2021) Vol. 50, pp. 8-16
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Accelerating antiviral drug discovery: lessons from COVID-19
Annette von Delft, Matthew D. Hall, Ann D. Kwong, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 7, pp. 585-603
Open Access | Times Cited: 94
Type I interferons and SARS-CoV-2: from cells to organisms
Paul Bastard, Qian Zhang, Shen‐Ying Zhang, et al.
Current Opinion in Immunology (2022) Vol. 74, pp. 172-182
Open Access | Times Cited: 70
SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains
Peter Radvák, Hyung‐Joon Kwon, Martina Košíková, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 92
SARS‐CoV‐2 and its variants of concern including Omicron: A never ending pandemic
Ranjan K. Mohapatra, Satwik Kuppili, Tarun Kumar Suvvari, et al.
Chemical Biology & Drug Design (2022) Vol. 99, Iss. 5, pp. 769-788
Open Access | Times Cited: 58
The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype
G. Tuba Barut, Nico Joël Halwe, Adriano Taddeo, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 48
Molecular Evolution of SARS-CoV-2 during the COVID-19 Pandemic
Luis Daniel González-Vázquez, Miguel Arenas
Genes (2023) Vol. 14, Iss. 2, pp. 407-407
Open Access | Times Cited: 27
Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern
Sreelekshmy Mohandas, Pragya D. Yadav, Gajanan Sapkal, et al.
EBioMedicine (2022) Vol. 79, pp. 103997-103997
Open Access | Times Cited: 35
Implications of inflammation: Bone and joint health with COVID-19
Aarush Sahni, Chamith S. Rajapakse, Shampa Chatterjee
Elsevier eBooks (2025), pp. 219-233
Closed Access
Development of broadly protective coronavirus vaccines: A joint NIAID-CEPI workshop report.
Jennifer L. Gordon, Erin L. Boespflug, Andrea Y Coleman, et al.
Vaccine (2025) Vol. 54, pp. 126909-126909
Open Access
Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer
Arielle Elkrief, Julie Wu, Chinmay Jani, et al.
Cancer Discovery (2021) Vol. 12, Iss. 2, pp. 303-330
Open Access | Times Cited: 33
SARS-CoV-2 variants of concern alpha, beta, gamma and delta have extended ACE2 receptor host ranges
Nazia Thakur, Giulia Gallo, Joseph Newman, et al.
Journal of General Virology (2022) Vol. 103, Iss. 4
Open Access | Times Cited: 23
Sulforaphane’s Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2)-Dependent and -Independent Mechanism of Anti-SARS-CoV-2 Activity
Ziqi Yan, Weifeng Liang, Lingxiang Zhu, et al.
Deleted Journal (2024) Vol. 1, Iss. 2, pp. 10010-10010
Open Access | Times Cited: 3
Airborne transmission of SARS-CoV-2
Andrew Fox‐Lewis
Elsevier eBooks (2024), pp. 141-152
Closed Access | Times Cited: 2
Influenza viruses and coronaviruses: Knowns, unknowns, and common research challenges
Olivier Terrier, Mustapha Si‐Tahar, Mariette Ducatez, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 12, pp. e1010106-e1010106
Open Access | Times Cited: 16
Animal models for studying coronavirus infections and developing antiviral agents and vaccines
Qisheng Lin, Chunni Lu, Yuqi Hong, et al.
Antiviral Research (2022) Vol. 203, pp. 105345-105345
Open Access | Times Cited: 9
Bacteria are a major determinant of Orsay virus transmission and infection in Caenorhabditis elegans
Brian G. Vassallo, Noémie Scheidel, Sylvia E. J. Fischer, et al.
eLife (2024) Vol. 12
Open Access | Times Cited: 1
Design and validation of an exposure system for efficient inter-animal SARS-CoV-2 airborne transmission in Syrian hamsters
Philip J. Kuehl, Justin Dearing, Adam D. Werts, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 3
Bacteria are a major determinant of Orsay virus transmission and infection in Caenorhabditis elegans
Brian G. Vassallo, Noémie Scheidel, Sylvia E. J. Fischer, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 3
The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype
G. Tuba Barut, Nico Joël Halwe, Adriano Taddeo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Spread of viruses, which measures are the most apt to control COVID-19?
Yacine Tandjaoui-Lambiotte, A. Lomont, Pierre Moënne-Locoz, et al.
Infectious Diseases Now (2022) Vol. 53, Iss. 2, pp. 104637-104637
Open Access | Times Cited: 5
Bacteria Are a Major Determinant of Orsay Virus Transmission and Infection in Caenorhabditis elegans
Brian G. Vassallo, Noémie Scheidel, Sylvia E. J. Fischer, et al.
(2023)
Open Access | Times Cited: 2
Thinking Outside the Box: Utilizing Nontraditional Animal Models for COVID-19 Research
Sachithra Gunasekara, Miruthula Tamil Selvan, Craig Miller, et al.
International Journal of Translational Medicine (2022) Vol. 2, Iss. 1, pp. 113-133
Open Access | Times Cited: 4
Evaluation of Binding and Neutralizing Antibodies for Inactivated SARS-CoV-2 Vaccine Immunization
Heng Zhao, Guorun Jiang, Cong Li, et al.
Diseases (2024) Vol. 12, Iss. 4, pp. 67-67
Open Access
Anti-SARS-CoV-2 antibodies in a nasal spray efficiently block viral transmission between ferrets
Kiira Gildemann, Mari-Liis Tsernant, Laura Liivand, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110326-110326
Open Access
Berbamine prevents SARS-CoV-2 entry and transmission
Srikanth Sadhu, Sandeep Goswami, Ritika Khatri, et al.
iScience (2024) Vol. 27, Iss. 12, pp. 111347-111347
Closed Access
Page 1 - Next Page

Scroll to top